Kees Nooter

10.9k total citations · 2 hit papers
149 papers, 9.1k citations indexed

About

Kees Nooter is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Kees Nooter has authored 149 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Oncology, 67 papers in Molecular Biology and 21 papers in Hematology. Recurrent topics in Kees Nooter's work include Drug Transport and Resistance Mechanisms (47 papers), Cancer therapeutics and mechanisms (37 papers) and Cancer Treatment and Pharmacology (19 papers). Kees Nooter is often cited by papers focused on Drug Transport and Resistance Mechanisms (47 papers), Cancer therapeutics and mechanisms (37 papers) and Cancer Treatment and Pharmacology (19 papers). Kees Nooter collaborates with scholars based in Netherlands, United States and North Macedonia. Kees Nooter's co-authors include Alex Sparreboom, Jaap Verweij, G. Stoter, Hans Gelderblom, Pieter Sonneveld, Hans Herweijer, Walter J. Loos, Herman Burger, Antonius W.M. Boersma and Peter de Bruijn and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Kees Nooter

148 papers receiving 8.8k citations

Hit Papers

Cremophor EL 2001 2026 2009 2017 2001 2001 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cremophor EL
    2001 1.4k citations Hans Gelderblom, Jaap Verweij et al. European Journal of Cancer profile →
  2. Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).
    2001 626 citations Ron H.J. Mathijssen, R J van Alphen et al. PubMed profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kees Nooter 5.4k 3.9k 1.0k 960 953 149 9.1k
T Tsuruo 5.6k 1.0× 5.4k 1.4× 318 0.3× 1.3k 1.4× 579 0.6× 155 9.7k
Merrill J. Egorin 5.5k 1.0× 5.9k 1.5× 622 0.6× 567 0.6× 1.6k 1.7× 380 14.2k
Gergely Szakács 6.0k 1.1× 4.7k 1.2× 861 0.8× 1.1k 1.2× 336 0.4× 141 9.8k
Yehuda G. Assaraf 5.7k 1.1× 9.4k 2.4× 1.9k 1.8× 1.1k 1.1× 1.4k 1.5× 262 17.0k
Antonio Tito Fojo 8.4k 1.5× 6.9k 1.8× 488 0.5× 1.3k 1.4× 473 0.5× 137 13.6k
G. Stoter 5.2k 1.0× 3.5k 0.9× 415 0.4× 742 0.8× 609 0.6× 261 10.8k
Douglas D. Ross 5.5k 1.0× 4.2k 1.1× 274 0.3× 1.6k 1.7× 591 0.6× 99 8.5k
Robert W. Robey 9.2k 1.7× 7.3k 1.9× 530 0.5× 2.3k 2.4× 722 0.8× 159 13.8k
Kenneth H. Cowan 6.1k 1.1× 7.6k 1.9× 209 0.2× 661 0.7× 945 1.0× 195 13.4k
Alan C. Sartorelli 4.9k 0.9× 8.5k 2.2× 213 0.2× 792 0.8× 686 0.7× 514 15.9k

Countries citing papers authored by Kees Nooter

Since Specialization
Citations

This map shows the geographic impact of Kees Nooter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kees Nooter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kees Nooter more than expected).

Fields of papers citing papers by Kees Nooter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kees Nooter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kees Nooter. The network helps show where Kees Nooter may publish in the future.

Co-authorship network of co-authors of Kees Nooter

This figure shows the co-authorship network connecting the top 25 collaborators of Kees Nooter. A scholar is included among the top collaborators of Kees Nooter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kees Nooter. Kees Nooter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nooter, Kees, et al.. (2005). Cytotoxicity of oleandrin isolated from the leaves of Nerium indicum Mill. on several human cancer cell lines. INDONESIAN JOURNAL OF PHARMACY. 96–103. 2 indexed citations
2.
Burger, Herman, Hans van Tol, Mariël Brok, et al.. (2005). Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps. Cancer Biology & Therapy. 4(7). 747–752. 159 indexed citations
3.
4.
Burger, Herman, John A. Foekens, Maxime P. Look, et al.. (2003). RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.. PubMed. 9(2). 827–36. 251 indexed citations
5.
Schenk, Paul W., Mariël Brok, Antonius W.M. Boersma, et al.. (2003). Anticancer Drug Resistance Induced by Disruption of the Saccharomyces cerevisiae NPR2 Gene: a Novel Component Involved in Cisplatin- and Doxorubicin-Provoked Cell Kill. Molecular Pharmacology. 64(2). 259–268. 42 indexed citations
6.
Gelderblom, Hans, et al.. (2002). Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel.. PubMed. 8(4). 1237–41. 83 indexed citations
7.
Schenk, Paul W., Antonius W.M. Boersma, Mariël Brok, et al.. (2002). Inactivation of the Saccharomyces cerevisiae SKY1Gene Induces a Specific Modification of the Yeast Anticancer Drug Sensitivity Profile Accompanied by a Mutator Phenotype. Molecular Pharmacology. 61(3). 659–666. 2 indexed citations
8.
Zuylen, Lia van, Alex Sparreboom, Ate van der Gaast, et al.. (2002). Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933. European Journal of Cancer. 38(8). 1090–1099. 55 indexed citations
9.
Burger, Herman, et al.. (2000). A Genome-Wide Screening in Saccharomyces cerevisiae for Genes That Confer Resistance to the Anticancer Agent Cisplatin. Biochemical and Biophysical Research Communications. 269(3). 767–774. 37 indexed citations
10.
Loos, Walter J., Peter de Bruijn, Lia van Zuylen, et al.. (1999). Determination of 5-fluorouracil in microvolumes of human plasma by solvent extraction and high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 735(2). 293–297. 28 indexed citations
11.
Sparreboom, Alex, Walter J. Loos, Kees Nooter, Gerrit Stoter, & Jaap Verweij. (1999). Liquid chromatographic analysis and preliminary pharmacokinetics of methotrexate in cancer patients co-treated with docetaxel. Journal of Chromatography B Biomedical Sciences and Applications. 735(1). 111–119. 23 indexed citations
12.
Mathijssen, Ron H.J., R J van Alphen, Maja J. De Jonge, et al.. (1999). Sparse-data set analysis for irinotecan and SN-38 pharmacokinetics in cancer patients co-treated with cisplatin. Anti-Cancer Drugs. 10(1). 9–16. 9 indexed citations
13.
Nooter, Kees, T.C. Kok, Fred T. Bosman, Kyra E. van Wingerden, & G. Stoter. (1998). Expression of the multidrug resistance protein (MRP) in squamous cell carcinoma of the oesophagus and response to pre-operative chemotherapy. European Journal of Cancer. 34(1). 81–86. 23 indexed citations
14.
Willem, Rudolph, Hassan Dalil, P. Broekaert, et al.. (1997). DI-n-BUTYL-, TRI-n-BUTYL- AND TRIPHENYLTIN STEROIDCARBOXYLATES: SYNTHESIS, NMR CHARACTERIZATION AND IN VITRO ANTITUMOUR ACTIVITY. Main Group Metal Chemistry. 20(8). 535–542. 27 indexed citations
15.
Verweij, Jaco J., et al.. (1997). 蛍光検出逆相高速液体クロマトグラフィーによるヒト血しょう中イリノテカン(CPT‐11)とその活性代謝産物SN‐38の定量. Journal of Chromatography B. 698. 277–285. 20 indexed citations
16.
Nooter, Kees, Guy Brutel de la Rivière, Maxime P. Look, et al.. (1997). The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer. British Journal of Cancer. 76(4). 486–493. 116 indexed citations
17.
18.
Nooter, Kees & G. Stoter. (1996). Molecular Mechanisms of Multidrug Resistance in Cancer Chemotherapy. Pathology - Research and Practice. 192(7). 768–780. 142 indexed citations
19.
20.
Nooter, Kees, et al.. (1975). Cytopathogenic XC assay for bone marrow from mice infected with murine leukemia viruses.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(8). 295–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T Tsuruo Breakdown of academic impact, for papers by Merrill J. Egorin Breakdown of academic impact, for papers by Gergely Szakács Breakdown of academic impact, for papers by Yehuda G. Assaraf Breakdown of academic impact, for papers by Antonio Tito Fojo Breakdown of academic impact, for papers by G. Stoter Breakdown of academic impact, for papers by Douglas D. Ross Breakdown of academic impact, for papers by Robert W. Robey Breakdown of academic impact, for papers by Kenneth H. Cowan Breakdown of academic impact, for papers by Alan C. Sartorelli
Rankless by CCL
2026